Author

Barbara Sinclair

Observed names: B Sinclair, Barbara L. Sinclair

Institution: Illawarra Shoalhaven Local Health District

Observed institutions: University of Wollongong, Illawarra Shoalhaven Local Health District, Illawarra Health and Medical Research Institute

ORCID: 0000-0002-7580-1940

Observed ORCID: 0000-0002-7580-1940

OpenAlex ID: A5103241765

Insight in substance use disorder: A systematic review of the literature

2020 · Dayle Raftery, Peter J. Kelly, et al. · Addictive Behaviors · 69

N-acetylcysteine (NAC) for methamphetamine dependence: A randomised controlled trial

2021 · Rebecca McKetin, Olivia M. Dean, et al. · EClinicalMedicine · 35

PDF

Integrated substance use rehabilitation in a secure forensic facility

2019 · Kerri Eagle, Trevor Ma, et al. · Journal of Forensic Practice · 22

A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine (“ice”) dependence

2019 · Rebecca McKetin, Olivia M. Dean, et al. · Trials · 18

PDF

Clinical and demographic characteristics of people who smoke versus inject crystalline methamphetamine in Australia: Findings from a pharmacotherapy trial

2020 · Rebecca McKETIN, Brendan Quinn, et al. · Drug and Alcohol Review · 15

PDF

Treatment Resistant and Resistant to Treatment? Evaluation of 40 Alcohol Dependent Patients Admitted for Involuntary Treatment

2015 · Glenys Dore, Barbara Sinclair, et al. · Alcohol and Alcoholism · 11

Mirtazapine for Methamphetamine Use Disorder

2026 · Rebecca McKetin, Steven Shoptaw, et al. · JAMA Psychiatry · 10

PDF

Investigating the management of alcohol‐related presentations in an Australian teaching hospital

2019 · Siyu Qian, Mudar Irani, et al. · Drug and Alcohol Review · 10

A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial

2024 · Rebecca McKetin, Tayla J. Degan, et al. · Trials · 8

Diagnostic accuracy for self‐reported methamphetamine use versus oral fluid test as the reference standard in a methamphetamine‐dependent intervention trial population

2022 · Gregory Carter, Matthew J. Spittal, et al. · Addiction · 8

Emergency Department Presentations of Patients with Alcohol use Disorders in an Australian Regional Health District

2022 · Jingxiang Zhang, Siyu Qian, et al. · Substance Abuse · 5

Predicting 28-day all-cause unplanned hospital re-admission of patients with alcohol use disorders: a machine learning approach

2025 · Jingxiang Zhang, Siyu Qian, et al. · Alcohol and Alcoholism · 3

Investigating the service utilization and pathways of patients with alcohol use disorders

2024 · Jingxiang Zhang, Siyu Qian, et al. · Alcohol and Alcoholism · 2

PDF

Mirtazapine for Methamphetamine Use Disorder: A Randomized Clinical Trial

2026 · R McKetin, S Shoptaw, et al. · Deakin Research Online (Deakin University)

The Tina Trial: Progress of a phase 3 randomised placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine ("ice") dependence

2023 · Joel Keygan, Lily Palmer, et al. · Deakin Research Online (Deakin University)

Investigating hepatitis C screening among people receiving opioid agonist treatment: A retrospective audit study

2023 · Frank Cordaro, Siyu Qian, et al. · Journal of Infection Prevention

PDF

Works count: 16

Citation count: 216

H-index: 8

I10-index: 8